Comparing the effects of Tranexamic acid and Mefenamic acid in treating heavy menstrual bleeding

Phase 3

• Conditions: menorrhagia.; Noninflammatory disorders of female genital tract; N80-N98

• Registration Number: IRCT2013011912190N1
• Lead Sponsor: Taleghani Hospital of Tehran

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

women aged 15-49 suffering from heavy menstrual bleeding or long menstrual duration. Exclusion criteria: organic causes were excluded by history, physical exam, lab test.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Menstrual duration. Timepoint: one month before treatment,two subsequent month during treatment and one month following treatment. Method of measurement: questionnaire.;Menstrual bleeding volume. Timepoint: one month before treatment,two subsequent month during treatment and one month following treatment. Method of measurement: Pictorial chart on which patients marked the type and the number of pads theyused during menstrual bleeding.

Secondary Outcome Measures

Name	Time	Method
Complication ,like vertigo, dyspepsia,epigasteric pain,thrombosis. Timepoint: one month following treatment. Method of measurement: questionnaire.;Choosing the drug if the problem recur. Timepoint: one month following treatment. Method of measurement: questionnaire.;Patient satisfaction with the treatment. Timepoint: one month following treatment. Method of measurement: questionnaire.